Saro H. Armenian, D.O., M.P.H. Growing up in Beirut, Lebanon, Saro H. Armenian, D.O., M.P.H., chair and professor in the City of Hope® of Hope Children’s Cancer Center, did not aspire to...

Leen Faytrouni It isn’t often that you find both a hero and a medical pioneer in the same family. But such is the case with teen sisters Leen and Jana Faytrouni...

Cancer is one of the most formidable challenges in health care, and those who treat it are the embodiment of unwavering dedication, compassion and expertise. At City of Hope®, our...

Bob Shank Cancer patients often experience the lowest points in their lives before hope slowly begins to emerge.For 70-year-old Bob Shank, the lowest of the lows and highest of highs...

City of Hope® treated the oldest person to be cured of blood cancer and then achieve remission for HIV after receiving a stem cell transplant from a donor with a...

Growing up in Iran, hematologist-oncologist Salman Otoukesh, M.D., always knew he wanted to be a physician. Inspired by his father, a pediatric nephrologist and professor still working in Iran...

According to preclinical research published online today in Cell, one of the world’s premier scientific journals, researchers at City of Hope® have discovered that a type of immune cell...

Ibrahim T. Aldoss, M.D., City of Hope associate professor in the Division of Leukemia and principal investigator for the AUGMENT-101 trial. City of Hope has announced that 23% of patients with relapsed or treatment-resistant KMT2Ar acute myeloid leukemia (AML), acute lymphoid leukemia (ALL) and mixed phenotype leukemia who took the...

Revumenib met its primary endpoint for efficacy in pivotal Phase 2 AUGMENT-101 trial and demonstrated favorable safety and tolerability in adult and pediatric patients with relapsed/refractory KMT2A-rearranged (KMT2Ar) acute myeloid...

In 2019, Paul Rudder, then 72, wanted to donate blood as he had done on a regular basis for many years. But when his blood was checked before donation, a...